Effect of PKG activation on recombinant GABAA receptors.
The effect of cGMP-dependent protein kinase (PKG) on recombinant human alpha 1 beta 2 gamma 2L GABAA receptors expressed in Xenopus oocytes was studied using the two-electrode voltage-clamp technique. The cGMP analog 8BrcGMP (1 mM) produced an increase in GABA-gated chloride currents. Intracellular injection of the PKG inhibitor peptide, PKGI, prevented the 8BrcGMP-mediated increase in the GABA response indicating that 8BrcGMP enhances GABAA receptor function via activation of PKG. Previous studies have shown that PKG phosphorylates a fusion protein corresponding to the intracellular loop of the beta 1 subunit [McDonald and Moss, J. Biol. Chem., 269 (1994) 18111-18117]. In the present study, site-directed mutagenesis of this phosphorylation site (beta 2ser410) failed to eliminate the effects of 8BrcGMP on the GABA response. These results suggest that there may be other sites on the receptor which are regulated by PKG or that PKG phosphorylates other proteins which may influence GABAA receptor function.
Leidenheimer
N J
NJ
Department of Pharmacology and Therapeutics, Louisiana State University Medical Center, Shreveport 71130-3932, USA.
D000818:Animals; D006152:Cyclic GMP / Q000031:analogs & derivatives / Q000494:pharmacology; D017869:Cyclic GMP-Dependent Protein Kinases / Q000187:drug effects / Q000378:metabolism*; D004789:Enzyme Activation; D005260:Female; D006801:Humans; D009865:Oocytes / Q000187:drug effects / Q000378:metabolism; D018408:Patch-Clamp Techniques; D010766:Phosphorylation; D011963:Receptors, GABA-A / Q000096:biosynthesis / Q000235:genetics*; D011994:Recombinant Proteins / Q000096:biosynthesis; D014982:Xenopus laevis
D011963:Receptors, GABA-A; D011994:Recombinant Proteins; C016276:8-bromocyclic GMP; D017869:Cyclic GMP-Dependent Protein Kinases; D006152:Cyclic GMP